| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10920783 | Radiotherapy and Oncology | 2005 | 9 Pages |
Abstract
Using T2-weighted MR, the visualization of an intraprostatic lesion is feasible. The inclusion of the GTVMRI into planning optimization leads to a modest increase in dose, without compromising the dose to the CTV, PTV and organs at risk. The clinical delivery of these plans runs without problems. Acute toxicity is mild.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gert De Meerleer, Geert Villeirs, Samuel Bral, Leen Paelinck, Werner De Gersem, Peter Dekuyper, Wilfried De Neve,